Botox Pre & Post Treatment

PRE-TREATMENT:

  • Women who are pregnant, nursing, or planning to be pregnant should not use Botox®

  • Avoid alcohol & blood thinners (aspirin, ibuprofen, etc) 24-48 hours prior to your treatment. This increases your chance of bruising.


POST-TREATMENT:

  • Please stay upright for 4 hours.

  • Avoid heavy lifting, no strenuous activity for 24 hours.

  • No hats or headbands after treatment. (Treatment day only)

  • Do not schedule a chemical peel, facials or massage for 2 weeks post treatment.

  • Exercise treated muscles intermittently for 90 minutes post treatment.

  • Try to sleep on your back with your head elevated for 1-2 nights.

  • The treatment area may be sensitive. This usually subsides in 1-12 hours.

  • Visible injection marks are normal. This will subside within an hour.

  • Do not scratch or pick the injection sites. 

  • You may apply ice, arnica or any other anti-inflammatory topical agent to treat or prevent pain, bruising or swelling.


PLEASE NOTE:

  • Treatment results will be visible in 2-6 days.

  • Final results in 14 days.

  • Final results are temporary.

  • 10% of people may not respond to treatment for unknown reasons. 

  • You can expect results to last 2-6 months.

  • Treatment is recommended every 3-4 months.

  • Skin rash, under or over correction.

POSSIBLE SIDE EFFECTS AND LESS COMMON COMPLICATIONS:

  • Side effects associated with the injections include: localized pain, infection, inflammation, tenderness, swelling, redness, and/or bleeding/bruising.

  • Less common reactions may include: headache, excessive weakness of the muscle, temporary eyelid drooping, temporary brow drooping, altered position of the eyebrow.

CONTRAINDICATIONS:

  • Current infection

  • Pregnant, planning to become pregnant or breastfeeding

  • Prior allergic reaction

  • Patients that are prescribed calcium channel blockers such as amlodipine,diltiazem, felodipine, isradipine, nifedipine,nicardipine, verapamil and nisoldipine, etc. 

  • Patients with diseases of the neuromuscular junction such as myasthenia gravis, Guillain-Barré syndrome, ALS.